community download

Presentation: Jeffrey Hackman

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Jeff Hackman is the Sr. Vice President, Commercial Operations for Intercell AG and President and CEO of Intercell USA. In this role, he supervises the global marketing and sales efforts, and commercial partnerships for the company focusing on the successful global launch of Intercell’s first licensed product, IXIARO/JESPECT®(Japanese Encephalitis vaccine).

We had the pleasure to find out more about the preclinical and clinical features of the novel high quality JEV vaccine Intercell is currently working on. A key take-away point is that partnerships are key to move projects like these forward and Intercell is no exception. Through a partnership concept Jeff Hackman is leading these efforts to move the vaccine into the pediatric arena of endemic countries.

To find out more about the concept and the launch of Intercell’s JEV vaccine, download the full presentation here.